Phoenix Children’s Hospital, is the first health system in the U.S. to receive and deploy the newly FDA-cleared Medtronic Stealth Autoguide™ platform.
Background
Stealth Autoguide combines advanced software, navigation and instrumentation to enable accuracy during surgery. Designed for accurate positioning of instruments to support a variety of neurological procedures, the Stealth Autoguide™ platform surgical tool is intended for use with Medtronic’s StealthStation™ system. Phoenix Children’s Hospital will use it in surgery for pediatric patients suffering from a range of neurological conditions. The technology can generally be used as a tool during stereoelectroencephalographies (sEEG), biopsies, and Visualase™ procedures.
Ranked a top pediatric neuroscience, neurosurgery and neurology program by U.S. News & World Report’s Best Children’s Hospitals, Barrow Neurological Institute (BNI) at Phoenix Children’s is eager to combine its deep bench of clinical talent with Medtronic’s cutting-edge innovation. BNI at Phoenix Children’s surgical staff have undergone comprehensive training with the Medtronic team as they prepared to use the Stealth Autoguide robotic guidance system in patient neurosurgery cases in early January.
Healthcare provider comments
“Phoenix Children’s is proud to invest in the best possible technology for use while we provide outstanding care to children,” said Daniel Ostlie, M.D., surgeon in chief and chair of Surgery at Phoenix Children’s. “We are committed to being at the forefront of surgical innovation and having the most advanced solutions for pediatric patients.”
“The Stealth Autoguide is a tremendous addition to the neurosurgical team’s tools at Phoenix Children’s,” said P. David Adelson, division chief of Neurosurgery and director of BNI at Phoenix Children’s. “Neurosurgery is such an intricate specialty, and having this technology at our fingertips perfectly aligns with our mission to provide state-of-the-art care to improve the health and quality of life for the children we see here.”
Company comments
“With our new technology deployed, we are thrilled to work with Phoenix Children’s and to support their mission of providing exceptional care for pediatric patients,” said Dave Anderson, vice president and general manager, Enabling Technologies, which is part of the Restorative Therapies Group at Medtronic.
Source: Medtronic, plc
published: January 20, 2020 in: Approval/Clearance, Launches / Withdrawals, Medtronic, Neuro, Robotics